Skip to main content

The Effect of Telemedicine-Based APAP Management on 24-Hour Ambulatory Blood Pressure in Patients with Obstructive Sleep Apnea: A Randomized Clinical Trial

In brief

Telemedicine matched clinic care for blood pressure after 3 months

In a randomized trial of 344 people with suspected sleep apnea, telemedicine-based auto-adjusting positive airway pressure management was noninferior to in-person care for 3-month change in 24-hour blood pressure. The between-group difference was less than 1 mmHg, within the prespecified 1.5-mmHg margin; however, 88 participants did not complete follow-up, and other measured outcomes showed no clear differences.

Journal
American journal of respiratory and critical care medicine (Q1)
Published
14 November 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Huijie Yi, Xiaosong Dong, Chi Zhang, Zhiyong Li, Wenjing Yang, Yuhua Zuo, et al.
PMID
43035945
DOI
10.1093/ajrccm/aamag627

Why clinicians should know about it

Abstract

RATIONALE: Telemedicine improves access to obstructive sleep apnea (OSA) care, but whether telemedicine-based auto-adjusting positive airway pressure (APAP) management is noninferior to in-person care for the 3-month change in 24-hour mean blood pressure (BP) remains uncertain. OBJECTIVES: To determine whether comprehensive telemedicine-based APAP management is noninferior to standard in-person care in reducing 24-hour mean BP in patients with OSA. METHODS: In this prospective, randomized non-inferiority trial, 344 participants with suspected OSA were randomized 1:1 to telemedicine-based (TM) or in-person (IP) management for 3 months. The primary outcome was the between-group difference in change in 24-hour mean BP. The prespecified non-inferiority margin was 1.5 mmHg. Secondary outcomes included APAP adherence, patient-centered outcomes and metabolic parameters. MEASUREMENTS AND MAIN RESULTS: Of 344 randomized participants, 256 completed the 3-month follow-up (127 IP and 129 TM). The between-group difference (TM - IP) in the change in 24-hour mean BP was -0.59 mmHg (95% CI, -2.42 to 1.25) in the intention-to-treat analysis and -1.21 mmHg (95% CI, -3.24 to 0.81) in the completer analysis. Both upper confidence limits were below the prespecified 1.5-mmHg non-inferiority margin. No clear evidence of between-group differences was observed in APAP adherence, patient-reported outcomes, or metabolic measures. CONCLUSIONS: Telemedicine-based APAP management was noninferior to in-person management for the 3-month change in 24-hour mean BP, using a prespecified margin of 1.5 mmHg. These findings support telemedicine as a potential alternative delivery model for blood pressure management in patients with OSA.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.